Insulin-like growth factor binding protein-3 (IGFBP-3) can inhibit cell growth by directly interacting with cells, as well as by forming complexes with IGF-I and IGF-II that prevent their growth-promoting activity. The present study examines the mechanism of inhibition of DNA synthesis by IGFBP-3 in
Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-β in mink lung epithelial cells
✍ Scribed by Feng Dong; Hai-Bin WU; Jiang Hong; Matthew M. Rechler
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 243 KB
- Volume
- 190
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Insulin‐like growth factor binding protein‐3 (IGFBP‐3) has been proposed to mediate the growth inhibitory effects of transforming growth factor (TGF)‐β in breast and prostate cancer cells. Both TGF‐β and exogenous IGFBP‐3 inhibit DNA synthesis in Mv1 mink lung epithelial cells (CCL64). The present study asks whether IGFBPs synthesized by CCL64 cells mediate growth inhibition by TGF‐β. CCL64 cells synthesize and secrete a single 34‐kDa IGFBP that was identified as IGFBP‐2 by immunoprecipitation and immunodepletion. Recombinant bovine IGFBP‐2 inhibited CCL64 DNA synthesis in serum‐free media in an IGF‐independent manner. Coincubation with Leu^60^‐IGF‐I, an IGF‐I analog that binds to IGFBPs with higher affinity than to IGF‐I receptors, decreased the inhibition by bIGFBP‐2. Leu^60^‐IGF‐I also decreased the inhibition of CCL64 DNA synthesis by TGF‐β by up to 70%, whereas Long‐R3‐IGF‐I, an IGF‐I analog with higher affinity for IGF‐I receptors than for IGFBPs, did not decrease inhibition, suggesting that the effect of Leu^60^‐IGF‐I resulted from its forming complexes with endogenous IGFBPs. Leu^60^‐IGF‐I did not decrease TGF‐β stimulation of a Smad3‐dependent reporter gene. Following incubation of intact CCL64 cells with bIGFBP‐2 at 0°C, bIGFBP‐2 was recovered in membrane fractions; membrane association was abolished by coincubation with Leu^60^‐IGF‐I. If exogenous and secreted IGFBP‐2 must bind to CCL64 cells to inhibit DNA synthesis, Leu^60^‐IGF‐I might reduce the inhibition of DNA synthesis by bIGFBP‐2 or TGF‐β by inhibiting the association of IGFBP‐2 in the media with CCL64 cells. Since TGF‐β does not increase IGFBP‐2 abundance, we propose that TGF‐β sensitizes CCL64 cells to the latent growth inhibitory activity of endogenous IGFBP‐2 by potentiating an intracellular IGFBP‐2 signaling pathway or by promoting the association of secreted IGFBP‐2 with the plasma membrane. J. Cell. Physiol. 190: 63–73, 2002. Published 2002 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract The present study examined the effects of all‐__trans__ retinoic acid (tRA) on proliferation and expression of the IGF system in Caco‐2 human colon adenocarcinoma cells. tRA inhibited Caco‐2 cell proliferation in a dose‐dependent manner, with a 40 ± 2% decrease in cell number observed 4
IGF-I is mitogenic for the bovine mammary epithelial cell line MAC-T. In addition, IGF-I specifically upregulates IGFBP-3 synthesis in these cells. To investigate this effect on cell growth and IGF-I responsiveness, cell lines were developed that constitutively express IGFBP-3. MAC-T cells transfect
Insulin-like growth factor-1, IGF-1, is believed to be an important anabolic modulator of cartilage metabolism whose action is mediated by high affinity cell surface receptors and bioactivity and bioavailability regulated, in part, by IGF-1 binding proteins (IGFBPs). Prostaglandin E 2 (PGE 2 ) stimu
## Abstract Insulin‐like growth factor 1 (IGF‐1) and its major binding protein, IGF binding protein 3 (IGFBP‐3) are implicated in lung cancer and other malignancies. We have previously shown that the combination of three major antioxidants [β‐carotene (BC), α‐tocopherol (AT) and ascorbic acid (AA)]